Kamala Harris refutes the idea of cannabis as a «gateway drug»
During an appearance on Jimmy Kimmel Live, U.S. Vice President Kamala Harris addressed the controversial topic of cannabis re-evaluation and its wider implications. She also took the opportunity to debunk one of the biggest myths used by supporters of cannabis prohibition.
Demystifying the theory of gateway drugs
Kamala Harris firmly rejected the long-held theory that the cannabis is a «gateway drug», a notion that has been the cornerstone of many drug policies in the past.
«Remember, there was a time when people said «marijuana is a gateway drug,» and those policies were doomed to failure,» she said.
This point of view is in line with a growing body of research indicating that cannabis does not lead to the use of harder substances. Instead, she says, the focus should be on more pressing issues such as opioid addiction and mental health resources.
Overestimating the impact of reclassification
During her interview, Ms. Harris also spoke of the the administration's recent proposal to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). This measure, while important, has been a source of confusion as to its real impact on criminal justice and resource allocation.
Harris suggested that this change would enable a better allocation of resources to combat addiction. However, the direct link between rescheduling and resource reallocation is unclear. Critics argue that if revaluation could relax research restrictions and potentially change the way cannabis is treated in the criminal justice system, it does not inherently provide a mechanism for redirecting resources as Ms. Harris suggested.
A lighter note: Kamala Kush
On a more humorous note, Ms. Harris's interview took an unexpected turn when she learned that a cannabis variety Kamala Kush. Her surprised reaction and refusal to engage with the product highlighted a lighter side to an otherwise very serious discussion. «Really? Really? I didn't know that,» she laughed. Although Jimmy Kimmel joked that she should have received the product as a gift, Ms. Harris made it clear that she wouldn't «touch it».
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
-
Cannabis in Africa1 week ago
Kenya Denies Rastafarians the Right to Use Cannabis


David
8 June 2024 at 12 h 59 min
So the gateway effect is mainly due to the fact that dealers sell everything. Indeed, many of my generation in their fifties have at one time or another been offered hard drugs (ecstasy, cocaine, heroin, etc etc). It was to combat this "gateway effect" that the Dutch authorities authorized coffee-shops. Separating the markets and supervising them have produced excellent results, notably low cannabis consumption among young people.